SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0000950133-01-000421
Filing Date
2001-02-08
Accepted
2001-02-08 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH TARGET S.A.

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D w45270sc13da.txt SC 13D/A 11239
  Complete submission text file 0000950133-01-000421.txt   13170
Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address STE 201 1204 KENSINGTON RD NW CALGARY ALBERTA CANA A0
SYNSORB BIOTECH INC (Subject) CIK: 0001025863 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-52837 | Film No.: 1528914
SIC: 2834 Pharmaceutical Preparations